J&J targets 2024 for Ottava FDA filing

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 07, 2023 at 11:23: PM
via The company expects to file a submission for an investigational device exemption in the second half of 2024 that will allow it to begin clinical trials for the robotic surgery system.

article source
 

<



Similar threads

cafead
Moderna targets $1.1B in R&amp;D spending cuts, drops 5 programs amid profitability pressures
Replies
0
Views
50
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J targets rare maternal-fetal diseases: &#039;We&#039;re going for this. No one else...
Replies
0
Views
61
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Medtech CDMO sector poised for M&amp;A rebound in 2023 amid ‘attractive’ targets: report
Replies
0
Views
202
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
25 Most Attractive Medtech M&amp;A Targets in 2022
Replies
0
Views
158
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
J&amp;J&#039;s Janssen inks $1B biobucks pact for Mersana&#039;s ADC tech in 3 targets
Replies
0
Views
121
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote